{"url":"https://lda.senate.gov/api/v1/filings/5e744d53-89df-4bf6-8065-9c4a9dd8ea4e/","filing_uuid":"5e744d53-89df-4bf6-8065-9c4a9dd8ea4e","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2020,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/5e744d53-89df-4bf6-8065-9c4a9dd8ea4e/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Laura Joshua","dt_posted":"2021-01-21T16:23:09.220000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"901 7th Street NW","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":314237,"url":"https://lda.senate.gov/api/v1/registrants/314237/","house_registrant_id":39145,"name":"INVARIANT LLC","description":"Government relations firm","address_1":"740 15th ST NW","address_2":"5th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAURA JOSHUA","contact_telephone":"+1 202-628-8952","dt_updated":"2026-01-20T22:53:50.106310-05:00"},"client":{"id":204908,"url":"https://lda.senate.gov/api/v1/clients/204908/","client_id":1006435,"name":"CURIO WELLNESS","general_description":"Maryland licensed cannabis company","client_government_entity":false,"client_self_select":null,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-03-09"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Advocate for a change in the Internal Revenue Code 280E to reduce taxation on legal cannabis business, including in H.R. 6800, the Heroes Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70863,"prefix":null,"prefix_display":null,"first_name":"QUINCY","nickname":null,"middle_name":null,"last_name":"ENOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73658,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitor cannabis-related legislation and advocated for regulatory changes for the treatment of cannabis-derived compounds.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70863,"prefix":null,"prefix_display":null,"first_name":"QUINCY","nickname":null,"middle_name":null,"last_name":"ENOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73658,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148636,"prefix":"ms","prefix_display":"MS.","first_name":"ANNABELL","nickname":null,"middle_name":"MCWHERTER","last_name":"STOKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BAN","general_issue_code_display":"Banking","description":"Monitor cannabis-related legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70863,"prefix":null,"prefix_display":null,"first_name":"QUINCY","nickname":null,"middle_name":null,"last_name":"ENOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73658,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}